January 22, 2016
January 22, 2016
January 15, 2016
Electronic cigarettes are widely promoted and used to help smokers quit traditional cigarettes, but a new analysis from UC San Francisco found that adult smokers who use e-cigarettes are actually 28 percent less likely to stop smoking cigarettes.
January 13, 2016
The NCCN Oncology Research Program has awarded five research grants to investigate the effectiveness of enzalutamide in mantle cell lymphoma and endometrial, hepatocellular, and prostate cancers.
December 18, 2015
December 14, 2015
A team of researchers at UC San Francisco has devised a new approach for early stage drug discovery that uses techniques from the world of computer vision in combination with a powerful new tool: a lineage of genetically modified cancer cells in a dish that change their appearance when treated with drugs targeting common disease pathways.
December 9, 2015
The lineup is finalized for the 2016 Personalized Medicine World Conference, with nine scheduled talks by UCSF leaders and faculty.
December 4, 2015
November 24, 2015
Keith Yamamoto, PhD, has spent his career doing basic research, and also working both to improve the practice of science and to amplify its impact beyond the walls of academia. Now, in his new role as UCSF’s first vice chancellor for Science Policy and Strategy, he’ll lead efforts to anticipate the needs of an increasingly dynamic biomedical research endeavor, and to position UCSF optimally, both by working within the University and by influencing and shaping science policy at the state and national levels and beyond.
November 18, 2015
Nobel laureate Elizabeth Blackburn, PhD, professor of biochemistry and biophysics at UC San Francisco, has been named the first woman president of the Salk Institute for Biological Sciences.
November 17, 2015
A $10 million gift from The Parker Foundation, founded by Silicon Valley entrepreneur and philanthropist Sean Parker, will establish a new research laboratory within the Diabetes Center at UC San Francisco devoted to understanding autoimmunity, in the hopes of laying the groundwork for new treatments for diseases ranging from type 1 diabetes to multiple sclerosis to rheumatoid arthritis.